George McAllister
Directeur Technique/Scientifique/R&D chez Psynova Neurotech Ltd.
Postes actifs de George McAllister
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Psynova Neurotech Ltd.
 Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de George McAllister
Anciens postes connus de George McAllister
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/08/1989 | 01/06/2006 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Directeur des opérations | - | - |
Statistiques
Internationale
| Royaume-Uni | 3 |
| Etats-Unis | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- George McAllister
- Expérience
